| pubmed-article:9625104 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9625104 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:9625104 | lifeskim:mentions | umls-concept:C0006675 | lld:lifeskim |
| pubmed-article:9625104 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
| pubmed-article:9625104 | lifeskim:mentions | umls-concept:C0006726 | lld:lifeskim |
| pubmed-article:9625104 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:9625104 | lifeskim:mentions | umls-concept:C0232970 | lld:lifeskim |
| pubmed-article:9625104 | lifeskim:mentions | umls-concept:C0489458 | lld:lifeskim |
| pubmed-article:9625104 | lifeskim:mentions | umls-concept:C1515075 | lld:lifeskim |
| pubmed-article:9625104 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:9625104 | pubmed:dateCreated | 1998-6-30 | lld:pubmed |
| pubmed-article:9625104 | pubmed:abstractText | We studied the biochemical effects of calcium supplementation during a 2-mo course in postmenopausal women (x +/- SD: 64 +/- 5 y of age and 14.5 +/- 6.7 y since menopause). The effects on calcium homeostasis and bone remodeling were assessed after 1 and 2 mo of daily administration of either calcium carbonate (1200 mg elemental Ca/d, n = 60) or a placebo (n = 56). The daily dietary calcium intake assessed before the beginning of calcium supplementation was 786 mg/d. We found a significant inverse relation between baseline intact parathyroid hormone (iPTH) and dietary calcium intake before supplementation (r = -0.48, P = 0.0002). A significant increase in urinary excretion of pyridinoline was observed when the dietary calcium intake was lower than the median value. Calcium supplementation resulted in a significant increase in 24-h urinary calcium (39%, P < 0.02) and a significant reduction of bone alkaline phosphatase at 2 mo and of all bone-resorption markers (hydroxyproline, pyridinoline, and deoxypyridinoline) at I and 2 mo without significant changes in 44-68 PTH fragments or iPTH concentrations. When the dietary calcium intake was low (mean +/- SD: 576 +/- 142 mg/d), calcium supplementation was responsible for a greater increase in urinary calcium excretion and a greater decrease in markers of bone turnover. The greatest variations were observed for deoxypyridinoline at 1 and 2 mo (-18.5%, P < 0.05) and for pyridinoline at 1 mo (-16.3%, P < 0.01). Two months of calcium supplementation in postmenopausal women was efficient in reducing markers of bone turnover, with a greater effect in women with a low dietary calcium intake. | lld:pubmed |
| pubmed-article:9625104 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9625104 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9625104 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9625104 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9625104 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9625104 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9625104 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9625104 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9625104 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9625104 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9625104 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:9625104 | pubmed:issn | 0002-9165 | lld:pubmed |
| pubmed-article:9625104 | pubmed:author | pubmed-author:SebertJ LJL | lld:pubmed |
| pubmed-article:9625104 | pubmed:author | pubmed-author:GuérisJJ | lld:pubmed |
| pubmed-article:9625104 | pubmed:author | pubmed-author:KamelSS | lld:pubmed |
| pubmed-article:9625104 | pubmed:author | pubmed-author:BrazierMM | lld:pubmed |
| pubmed-article:9625104 | pubmed:author | pubmed-author:LiénardJJ | lld:pubmed |
| pubmed-article:9625104 | pubmed:author | pubmed-author:FardellonePP | lld:pubmed |
| pubmed-article:9625104 | pubmed:author | pubmed-author:GrauletA MAM | lld:pubmed |
| pubmed-article:9625104 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9625104 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:9625104 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9625104 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9625104 | pubmed:pagination | 1273-8 | lld:pubmed |
| pubmed-article:9625104 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:meshHeading | pubmed-meshheading:9625104-... | lld:pubmed |
| pubmed-article:9625104 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9625104 | pubmed:articleTitle | Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake. | lld:pubmed |
| pubmed-article:9625104 | pubmed:affiliation | Department of Rheumatology, CHU, Amiens, France. | lld:pubmed |
| pubmed-article:9625104 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9625104 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9625104 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9625104 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9625104 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9625104 | lld:pubmed |
